AGP

Artia Global Partners Portfolio holdings

AUM $622M
1-Year Est. Return 234.78%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+234.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$568M
AUM Growth
+$180M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$21.2M
2
+$20.2M
3
+$13.8M
4
SLNO icon
Soleno Therapeutics
SLNO
+$13.2M
5
QURE icon
uniQure
QURE
+$12M

Top Sells

1
+$56.9M
2
+$3M
3
+$2.51M
4
LLY icon
Eli Lilly
LLY
+$1.49M
5
SRRK icon
Scholar Rock
SRRK
+$1.05M

Sector Composition

1 Healthcare 95.37%
2 Financials 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$30.2B
$105M 18.55%
732,212
-20,500
ARGX icon
2
argenx
ARGX
$45.8B
$57.8M 10.16%
78,311
SLNO icon
3
Soleno Therapeutics
SLNO
$2.14B
$45.4M 8%
672,176
+177,752
VRNA
4
DELISTED
Verona Pharma
VRNA
$40.4M 7.12%
379,004
-545,200
QURE icon
5
uniQure
QURE
$1.12B
$38.5M 6.77%
+658,839
MRUS
6
DELISTED
Merus
MRUS
$27.9M 4.92%
296,750
UGL icon
7
ProShares Ultra Gold
UGL
$1.37B
$24.8M 4.36%
+537,372
LLY icon
8
Eli Lilly
LLY
$900B
$21.9M 3.85%
28,700
-2,000
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$117B
$21.6M 3.8%
55,100
+50,700
ABVX
10
Abivax
ABVX
$8.67B
$19.1M 3.37%
+225,453
TRVI icon
11
Trevi Therapeutics
TRVI
$1.5B
$18.3M 3.22%
1,999,702
+687,862
BSX icon
12
Boston Scientific
BSX
$107B
$17.9M 3.15%
183,200
+28,000
ALNY icon
13
Alnylam Pharmaceuticals
ALNY
$42.9B
$15.8M 2.77%
34,570
+13,600
DGX icon
14
Quest Diagnostics
DGX
$22.1B
$15.6M 2.74%
81,717
AZN icon
15
AstraZeneca
AZN
$302B
$14.6M 2.58%
190,752
EYPT icon
16
EyePoint Inc
EYPT
$1.3B
$8.95M 1.57%
628,367
+311,667
REGN icon
17
Regeneron Pharmaceuticals
REGN
$80.3B
$6M 1.06%
10,671
NAMS icon
18
NewAmsterdam Pharma
NAMS
$3.43B
$5.54M 0.98%
194,838
+167,519
RVMD icon
19
Revolution Medicines
RVMD
$19.5B
$4.87M 0.86%
104,190
RNAM
20
DELISTED
Avidity Biosciences
RNAM
$4.8M 0.84%
110,100
+75,500
DNTH icon
21
Dianthus Therapeutics
DNTH
$3.42B
$4.28M 0.75%
+108,723
IONS icon
22
Ionis Pharmaceuticals
IONS
$12.4B
$3.94M 0.69%
+60,176
VKTX icon
23
Viking Therapeutics
VKTX
$3.88B
$3.84M 0.68%
146,179
+49,700
SRRK icon
24
Scholar Rock
SRRK
$4.51B
$3.59M 0.63%
96,285
-30,000
ABBV icon
25
AbbVie
ABBV
$407B
$3.36M 0.59%
14,500
1
2 3